Bide Pharmatech Co., Ltd. (SHA:688073)

China flag China · Delayed Price · Currency is CNY
61.93
+3.65 (6.26%)
At close: Feb 3, 2026
27.74%
Market Cap5.34B +32.3%
Revenue (ttm)1.27B +15.6%
Net Income153.31M +91.6%
EPS1.75 +95.5%
Shares Out86.15M
PE Ratio35.39
Forward PE35.09
Dividend0.90 (1.54%)
Ex-Dividend DateJun 9, 2025
Volume1,929,266
Average Volume1,289,451
Open58.96
Previous Close58.28
Day's Range58.90 - 62.60
52-Week Range34.30 - 82.88
Beta0.80
RSI40.66
Earnings DateApr 23, 2026

About Bide Pharmatech

Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 129
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688073
Full Company Profile

Financial Performance

In 2024, Bide Pharmatech's revenue was 1.10 billion, an increase of 0.93% compared to the previous year's 1.09 billion. Earnings were 117.43 million, an increase of 7.17%.

Financial Statements